title: Validation of a commercially available anti-REDD1 antibody using RNA interference and REDD1-/- mouse embryonic fibroblasts.
abstract: REDD1 is a transcriptional target gene of p53 and HIF-1, and an inhibitor of mTOR (mechanistic target of rapamycin) complex 1 (mTORC1)-signaling through PP2A-dependent interaction, making it an important convergence point of both tumor suppression and cell growth pathways. In accordance with this positioning, REDD1 levels are transcriptionally upregulated in response to a variety of cellular stress factors such as nutrient deprivation, hypoxia and DNA damage. In the absence of such conditions, and in particular where growth factor signaling is activated, REDD1 expression is typically negligible; therefore, it is necessary to induce REDD1 prior to experimentation or detection in model systems. Here, we evaluated the performance of a commercially available polyclonal antibody recognizing REDD1 by Western blotting in the presence of thapsigargin, a pharmacological inducer of ER stress well known to upregulate REDD1 protein expression. Further, REDD1 antibody specificity was challenged in HEK-293 cells in the presence of RNA interference and with a REDD1 (-/-) mouse embryonic fibroblast knockout cell line. Results showed reproducibility and specificity of the antibody, which was upheld in the presence of thapsigargin treatment. We conclude that this antibody can be used to reliably detect REDD1 endogenous expression in samples of both human and mouse origin.
authors.affiliation: Proteintech Group, Manchester, UK.
authors.forename: Deborah L
authors.initials: DL
authors.lastname: Grainger
authors.affiliation: Department of Cellular and Molecular Physiology, Penn State University College of Medicine, Hershey, PA, USA.
authors.forename: Lydia
authors.initials: L
authors.lastname: Kutzler
authors.affiliation: Department of Cellular and Molecular Physiology, Penn State University College of Medicine, Hershey, PA, USA.
authors.forename: Sharon L
authors.initials: SL
authors.lastname: Rannels
authors.affiliation: Department of Cellular and Molecular Physiology, Penn State University College of Medicine, Hershey, PA, USA.
authors.forename: Scot R
authors.initials: SR
authors.lastname: Kimball
keywords: DDIT4; REDD1; mTOR; thapsigargin